CSBR vs LPTX
Comparison between Champions Oncology Inc (CSBR, Company) and Leap Therapeutics Inc (LPTX, Company).
Both CSBR and LPTX are from the Healthcare sector.
5-Year PerformanceCSBR has outperformed LPTX, delivering a return of -10.5% compared to -33.2%
CSBR vs LPTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CSBR vs LPTX - Historical Returns
Returns include dividend reinvestment.
CSBR vs LPTX - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | CSBR | LPTX |
|---|---|---|
| 2026 | -9.91% | N/A |
| 2025 | -15.73% | -36.34% |
| 2024 | +48.01% | -38.44% |
| 2023 | +27.15% | -3.60% |
| 2022 | -46.82% | -86.57% |
| 2021 | -22.59% | +48.62% |
| 2020 | +32.56% | +112.26% |
| 2019 | +5.58% | -54.10% |
| 2018 | +94.28% | -67.79% |
| 2017 | +36.14% | -20.61% |
| 2016 | -33.07% | N/A |
| 2015 | -40.50% | N/A |
| 2014 | -58.33% | N/A |
| 2013 | +300.00% | N/A |
| 2012 | -60.00% | N/A |
| 2011 | -16.67% | N/A |
| 2010 | +12.50% | N/A |
| 2009 | -25.93% | N/A |
| 2008 | -20.00% | N/A |
| 2007 | +133.33% | N/A |
CSBR vs LPTX Drawdown Comparison
The maximum drawdown for CSBR was -94.13%, occurring on Sep 16, 2016. This drawdown has not yet recovered.
The maximum drawdown for LPTX was -99.76%, occurring on Aug 14, 2025. This drawdown has not yet recovered.
The current CSBR drawdown is -76.19%. The current LPTX drawdown is -97.95%.
| Rank | CSBR | LPTX |
|---|---|---|
| #1 | -94.13% Oct 24, 2007 - Sep 16, 2016 | -99.76% Apr 12, 2018 - Aug 14, 2025 |
| #2 | -58.33% Feb 2, 2007 - May 31, 2007 | -46.34% Mar 8, 2017 - Apr 5, 2018 |
| #3 | -35.71% Jun 1, 2007 - Oct 10, 2007 | -28.81% Jan 26, 2017 - Mar 7, 2017 |
| #4 | -12.71% Oct 18, 2007 - Oct 23, 2007 | -9.00% Apr 5, 2018 - Apr 12, 2018 |
Correlation
Correlation between CSBR and LPTX is -0.19 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks